-
公开(公告)号:US20190388416A1
公开(公告)日:2019-12-26
申请号:US16540552
申请日:2019-08-14
申请人: ARADIGM CORPORATION
发明人: DAVID C. CIPOLLA , James BLANCHARD
摘要: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
-
公开(公告)号:US10420765B2
公开(公告)日:2019-09-24
申请号:US15299284
申请日:2016-10-20
申请人: ARADIGM CORPORATION
发明人: David C. Cipolla , James Blanchard
摘要: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
-
3.
公开(公告)号:US20170184620A1
公开(公告)日:2017-06-29
申请号:US15457510
申请日:2017-03-13
发明人: Igor Gonda , Homer A. Boushey
IPC分类号: G01N33/94 , G01N33/58 , A61K31/352
CPC分类号: G01N33/94 , A61B5/082 , A61B5/145 , A61B5/14507 , A61B5/150015 , A61B5/4211 , A61K31/352 , G01N33/58 , G01N33/6893 , G01N2800/06 , Y10T436/142222
摘要: A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also expanded into quantitative analysis, enabling the estimation of either the concentration, or the amount, or both, of the gastrointestinal contents that entered the respiratory tract. The invention also provides methods of treatment based on the identification of aspiration using the methods of the invention.
-
公开(公告)号:US20170035753A1
公开(公告)日:2017-02-09
申请号:US15299284
申请日:2016-10-20
申请人: ARADIGM CORPORATION
发明人: DAVID C. CIPOLLA , James BLANCHARD
IPC分类号: A61K31/496 , A61K47/22 , A61K9/00 , A61K9/127
摘要: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
摘要翻译: 公开了一种抗生素药物如环丙沙星的浓缩可吸入制剂。 抗生素用含有抗生素的乙酸钠和脂质体配制。 该制剂被雾化并吸入以治疗呼吸道感染和其他医学状况。
-
公开(公告)号:US09511199B2
公开(公告)日:2016-12-06
申请号:US14157134
申请日:2014-01-16
申请人: ARADIGM CORPORATION
CPC分类号: A61M15/009 , A61M15/0031 , A61M15/0043 , A61M15/0045 , A61M15/0051 , A61M15/0055 , Y10T29/49826
摘要: A nozzle comprising a thin, flexible substantially planar polymeric film having a plurality of pores with structures allowing for generation of an aerosol at reduced extrusion pressure is disclosed. The pores can comprise at least two sections, or steps, in which the thickness of the membrane is reduced in stepwise fashion, or the pores can be tapered. Nozzles formed comprising pores having such structures permit aerosol generation at lower extrusion pressures, thereby allowing for decreased weight of aerosolization devices, increased efficiency, increased portability and increased battery life. The pore structures also allow for the use of thicker, more easily processed polymeric films in manufacturing while having a thinner, more efficient aerosolization area. The use of decreased extrusion pressures also results in increased uniformity in aerosol generation and improved reliability of other components.
-
公开(公告)号:US20160120806A1
公开(公告)日:2016-05-05
申请号:US14993281
申请日:2016-01-12
申请人: ARADIGM CORPORATION
发明人: David C. CIPOLLA , Igor GONDA
IPC分类号: A61K9/127 , A61K31/496
CPC分类号: A61K9/127 , A61K9/0078 , A61K9/1277 , A61K31/496 , A61K47/26 , Y02A50/406
摘要: A formulation is disclosed which is comprised of a first solvent having a first active ingredient dissolved therein a plurality of microenvironments dispersed in the first solvent, the microenvironment being comprised of a shell having a dimension in a range of 50 nanometers to 100, the shell comprising an internal volume comprising a second solvent having a second active ingredient dissolved therein and nanocrystals of the second active ingredient.
摘要翻译: 公开了一种配方,其由具有溶解在其中的分散在第一溶剂中的多个微环境的第一活性成分的第一溶剂组成,微环境由尺寸在50纳米至100范围内的壳体组成,壳体包含 内部体积,其包含溶解有第二活性成分的第二溶剂和第二活性成分的纳米晶体。
-
公开(公告)号:US09844548B2
公开(公告)日:2017-12-19
申请号:US15362405
申请日:2016-11-28
申请人: ARADIGM CORPORATION
发明人: Igor Gonda , James Blanchard , David C. Cipolla
IPC分类号: A61K9/127 , A61K31/496 , A61K9/12 , A61K45/06 , A61K9/00
CPC分类号: A61K31/496 , A61K9/0073 , A61K9/0078 , A61K9/12 , A61K9/127 , A61K45/06 , Y02A50/404
摘要: Methods of treatment of NTM lung infections using formulations of liposomal ciprofloxacin. Specific liposome formulations and delivery of such for treatment of respiratory tract infections and other medical conditions, and devices and formulations used in connection with such are described.
-
8.
公开(公告)号:US09421185B2
公开(公告)日:2016-08-23
申请号:US14204826
申请日:2014-03-11
发明人: Igor Gonda , Homer A. Boushey
IPC分类号: A61B5/00 , A61K31/352 , A61B5/08 , G01N33/68 , A61B5/145
CPC分类号: A61K31/352 , A61B5/082 , A61B5/14 , A61B5/145 , A61B5/14507 , A61B5/150015 , A61B5/4211 , G01N33/6893 , G01N2800/06 , Y10T436/142222
摘要: A method of diagnosing in a subject for the purpose of determining if the subject's gastrointestinal contents has entered the subject's respiratory tract. The qualitative analysis can be also expanded into quantitative analysis, enabling the estimation of either the concentration, or the amount, or both, of the gastrointestinal contents that entered the respiratory tract. The invention also provides methods of treatment based on the identification of aspiration using the methods of the invention.
-
公开(公告)号:US20150202201A1
公开(公告)日:2015-07-23
申请号:US14676367
申请日:2015-04-01
申请人: ARADIGM CORPORATION
发明人: DAVID C. CIPOLLA , JAMES BLANCHARD
IPC分类号: A61K31/496 , A61K9/00 , A61K9/127
CPC分类号: A61K31/496 , A61K9/0043 , A61K9/0073 , A61K9/0078 , A61K9/12 , A61K9/127 , A61K9/5084 , A61K45/06 , A61K47/22
摘要: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
-
公开(公告)号:US20150071992A1
公开(公告)日:2015-03-12
申请号:US14552817
申请日:2014-11-25
申请人: ARADIGM CORPORATION
发明人: DAVID C. CIPOLLA , JAMES BLANCHARD
IPC分类号: A61K9/12 , A61K31/496 , A61K45/06 , A61K9/127
CPC分类号: A61K31/496 , A61K9/0043 , A61K9/0073 , A61K9/0078 , A61K9/12 , A61K9/127 , A61K9/5084 , A61K45/06 , A61K47/22
摘要: A concentrated inhalable formulation of an antibiotic drug such as ciprofloxacin is disclosed. The antibiotic is formulated with sodium acetate and liposome which incorporate antibiotic. The formulation is aerosolized and inhaled for treatment of respiratory tract infections and other medical conditions.
摘要翻译: 公开了一种抗生素药物如环丙沙星的浓缩可吸入制剂。 抗生素用含有抗生素的乙酸钠和脂质体配制。 该制剂被雾化并吸入以治疗呼吸道感染和其他医学状况。
-
-
-
-
-
-
-
-
-